Insights into the Interaction of N-APP with Death Receptor 6 in Inducing Neuronal Apoptosis
Overview
Alzheimer’s Disease (AD) is a progressive neurodegenerative disease with a devastating clinical course yet currently lacks an effective treatment method. A recently proposed biochemical model for neuronal damage revolves around on a novel protein-protein interaction between an N-terminal fragment of the amyloid precursor protein (N-APP) and death cell receptor six (DR6) and establishes a framework for understanding AD pathophysiology. To better discern the interactions of N-APP with DR6 and the roles of aberrant metal ions (Cu, Zn) in N-APP-DR6 binding, the interaction mechanism of N-APP with DR6 in mediating neuronal cell apoptosis was studied. To this end, truncated N-APP and DR6 were cloned, expressed and purified. The interaction between N-APP and DR6 was investigated in the presence and absence of copper and zinc ions. Thermodynamic studies indicated that N-APP126 binds with DR6 via hydrophobic interactions with stronger binding between N-APP286 and DR6 than N-APP 126 with DR6 due to the additional acidic region of N-APP286. Furthermore, Cu/Zn can promote the binding between N-APP and DR6, and the binding of N-APP and DR6 promotes neuronal apoptosis, a vital component of AD pathophysiology. These results on the functions of N-APP(18-286) and DR6(41-218) and the underlying binding mechanism directly supplement the design of novel structure-based antagonists in retarding AD progression.
Awards (1)
- University of Arizona: Tuition Scholarship Award
Competition history
- ISEF 2017
Resources
Related projects
ISEF · 2024
A Mechanistic Analysis of Intraneuronal Amyloid Beta Aggregation Caused by Cellular Dysfunction in Alzheimer’s Disease
ISEF · 2024
Targeting Amyloid-ß Plaques: In silico Protein Modeling of Novel Antibody for Halting Alzheimer's Disease Progression
ISEF · 2016
Biochemical Characterization and Imaging of Arc: Insights into Neurodegeneration and Alzheimer’s Development
ISEF · 2016
Deciphering the Roles and Mechanism of Zn7MT3 in Abating Neuronal Cytotoxicity - Year Two
ISEF · 2015
High Throughput AD Drug Screening of Alpha-Secretase Activity Modulators as a Novel Model for Alzheimer's Disease
ISEF · 2014
A New Pathway for Alzheimer’s Drugs: Modification of BACE1 to Decrease the Release of Beta Amyloid in the Brain
ISEF · 2022
Associations of Genetic SNPs With AD, Neuropathology, and Gene Expression Offers Novel Insight Into AD
ISEF · 2024
Neuropath: Multi-Computational Framework for Developing a Receptor-Based Transcytosis Approach to Facilitate BDNF Transmission for Alzheimer’s Progression Prevention
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair